INTERVIEW 82 FEED & ADDITIVE MAGAZINE February 2026 Could you provide some insight into your current organizational structure in global markets? As you move forward as A&P Nutrition, do you plan to make any changes to this international setup? A&P Nutrition operates through a globally distributed, locally rooted structure with centralized leadership for the feed additive business. The integration of agromed and PATENT CO. has led to aligned sales organizations, a unified market approach, and a strong technical team supporting customers across more than 50 countries. Moving forward, we do not anticipate major structural changes, but we will continue refining and strengthening our international setup. This includes expanding customer‑facing capabilities, enhancing technical and analytical services, and selectively growing our presence in key regions. Any evolution will follow the same bottom‑up, people‑driven approach that guided our integration, ensuring we remain globally coordinated, locally relevant, and deeply connected to our customers’ needs. How will this restructuring and rebranding impact your market presence? Which factors do you believe will most strengthen your competitiveness in the global arena during this process? The restructuring and rebranding significantly strengthens our global market presence by uniting the complementary strengths of agromed and PATENT CO. under one coordinated, centrally managed structure. What truly elevates our competitiveness is the combination of our holistic portfolio, our strong technical and analytical expertise, and our shift toward solution‑driven, customer‑specific support. We are certainly not stopping at our current problem-solving capabilities. A major part of building the A&P Nutrition brand was defining a clear business strategy, and this process has given us a precise roadmap for the future — including the key projects where we plan to invest. For us, this means continuous improvement and long-term relevance in the market. For our customers, it means a steady flow of fresh, up-todate solutions that address their evolving needs. This commitment to ongoing development is what ensures we remain a reliable and forward-thinking partner. You noted that your portfolio has been "updated and expanded" following the merger. What innovations can customers expect regarding products, technical services, and analytical support in the coming period? How will the rebranding drive innovation and growth? Our R&D and innovation pipeline is driven by two main streams: continuous improvement of our existing products and the development of entirely new solutions. Ongoing enhancements are closely linked to our mycotoxin management portfolio, where we are enriching our approach and consistently elevating product performance. At the same time, we are investing in two highly promising areas: alternative protein sources, and probiotics and postbiotics. I am particularly excited about these developments, as they have the potential to significantly enhance efficacy while supporting animal stability, resilience, and overall health. What key trends do you think will stand out in the animal nutrition and feed additives market in 2026? In light of sustainability goals, evolving regulations, and economic pressures, what do you believe will be the industry’s greatest challenge? The animal nutrition sector is advancing across multiple interconnected innovation frontiers with the potential to significantly transform production in the near future. Key developments include: • Alternative proteins that break the soy - fish meal paradigm - such as precision fermentation creating animal-identical proteins with net-zero carbon impact, insect protein scaling to 0.5–1.5 million tons annually, and microalgae delivering 55–76% protein with added bioactive compounds - thereby decoupling animal production from traditional agriculture’s environmental footprint. • AI-powered precision nutrition is shifting feeding strategies from standardized herd approaches to individualized regimes, achieving 5–10% milk yield increases, reducing feed costs, and identifying high-methane-emitting animals with 80% accuracy. • Gut health revolution, driven by pro- and postbiotics, is expanding into a $6.5 billion market by 2032, enhancing nutrient absorption by 15–20% and replacing antibiotics,
RkJQdWJsaXNoZXIy MTUxNjkxNQ==